Sign in

CIK 0001341235 · Non-accelerated filer<br>Smaller reporting company

Aldeyra Therapeutics, Inc.

Sign in to watch
Ticker
ALDX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
781-761-4904
Business address
23 BRADFORD STREET, SUITE 1, CONCORD, MA, 01742
Former names
Aldexa Therapeutics, Inc., Neuron Systems Inc
  1. 4 Open-market buy 10% owner bought 504,272 shares at an average $3.84 ($1,934,505)
  2. 4 Open-market sale See Remarks sold 13,201 shares at $3.41 ($44,968)
  3. 4 Open-market sale Chief Development Officer sold 29,768 shares at an average $3.31 ($98,605)
  4. 4 Open-market sale President and CEO sold 183,238 shares at an average $3.17 ($580,760)
  5. 4 Open-market sale 10% owner sold 2,756,499 shares at an average $1.62 ($4,453,308)
  6. 4 Shares withheld for taxes President and CEO gave up 73,807 shares (to pay taxes)
  7. 4 Option exercise Director acquired 5,437 shares (option exercise)
  8. 4 Option exercise Director acquired 9,604 shares (option exercise)
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Option exercise Director acquired 9,604 shares (option exercise)
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Grant or award President and CEO acquired 238,750 shares (grant or award)
  19. 4 Open-market buy 10% owner bought 115,000 shares at an average $7.55 ($867,750)
  20. 4 Open-market buy 10% owner bought 97,000 shares at $7.24 ($702,280)

Page 3 of 12 · 223 filings